169 related articles for article (PubMed ID: 26437761)
1. Sodium nitrate alleviates functional muscle ischaemia in patients with Becker muscular dystrophy.
Nelson MD; Rosenberry R; Barresi R; Tsimerinov EI; Rader F; Tang X; Mason O; Schwartz A; Stabler T; Shidban S; Mobaligh N; Hogan S; Elashoff R; Allen JD; Victor RG
J Physiol; 2015 Dec; 593(23):5183-200. PubMed ID: 26437761
[TBL] [Abstract][Full Text] [Related]
2. Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
Martin EA; Barresi R; Byrne BJ; Tsimerinov EI; Scott BL; Walker AE; Gurudevan SV; Anene F; Elashoff RM; Thomas GD; Victor RG
Sci Transl Med; 2012 Nov; 4(162):162ra155. PubMed ID: 23197572
[TBL] [Abstract][Full Text] [Related]
3. Functional muscle ischemia in Duchenne and Becker muscular dystrophy.
Thomas GD
Front Physiol; 2013 Dec; 4():381. PubMed ID: 24391598
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-dependent attenuation of noradrenaline-induced vasoconstriction is impaired in the canine model of Duchenne muscular dystrophy.
Kodippili K; Hakim CH; Yang HT; Pan X; Yang NN; Laughlin MH; Terjung RL; Duan D
J Physiol; 2018 Nov; 596(21):5199-5216. PubMed ID: 30152022
[TBL] [Abstract][Full Text] [Related]
5. Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function.
Zhao J; Yang HT; Wasala L; Zhang K; Yue Y; Duan D; Lai Y
Mol Med; 2019 Jul; 25(1):31. PubMed ID: 31266455
[TBL] [Abstract][Full Text] [Related]
6. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.
Lai Y; Thomas GD; Yue Y; Yang HT; Li D; Long C; Judge L; Bostick B; Chamberlain JS; Terjung RL; Duan D
J Clin Invest; 2009 Mar; 119(3):624-35. PubMed ID: 19229108
[TBL] [Abstract][Full Text] [Related]
7. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase.
Thomas GD; Shaul PW; Yuhanna IS; Froehner SC; Adams ME
Circ Res; 2003 Mar; 92(5):554-60. PubMed ID: 12600881
[TBL] [Abstract][Full Text] [Related]
8. Dystrophin R16/17-syntrophin PDZ fusion protein restores sarcolemmal nNOSμ.
Patel A; Zhao J; Yue Y; Zhang K; Duan D; Lai Y
Skelet Muscle; 2018 Nov; 8(1):36. PubMed ID: 30466494
[TBL] [Abstract][Full Text] [Related]
9. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy.
Sander M; Chavoshan B; Harris SA; Iannaccone ST; Stull JT; Thomas GD; Victor RG
Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13818-23. PubMed ID: 11087833
[TBL] [Abstract][Full Text] [Related]
10. Sarcolemmal targeting of nNOSμ improves contractile function of mdx muscle.
Rebolledo DL; Kim MJ; Whitehead NP; Adams ME; Froehner SC
Hum Mol Genet; 2016 Jan; 25(1):158-66. PubMed ID: 26604149
[TBL] [Abstract][Full Text] [Related]
11. Perspective: Spectrin-Like Repeats in Dystrophin Have Unique Binding Preferences for Syntrophin Adaptors That Explain the Mystery of How nNOSμ Localizes to the Sarcolemma.
Percival JM
Front Physiol; 2018; 9():1369. PubMed ID: 30349485
[TBL] [Abstract][Full Text] [Related]
12. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
[TBL] [Abstract][Full Text] [Related]
13. Role of neuronal nitric oxide synthase (nNOS) in Duchenne and Becker muscular dystrophies - Still a possible treatment modality?
Dombernowsky NW; Ölmestig JNE; Witting N; Kruuse C
Neuromuscul Disord; 2018 Nov; 28(11):914-926. PubMed ID: 30352768
[TBL] [Abstract][Full Text] [Related]
14. Variable phenotype of del45-55 Becker patients correlated with nNOSμ mislocalization and RYR1 hypernitrosylation.
Gentil C; Leturcq F; Ben Yaou R; Kaplan JC; Laforet P; Pénisson-Besnier I; Espil-Taris C; Voit T; Garcia L; Piétri-Rouxel F
Hum Mol Genet; 2012 Aug; 21(15):3449-60. PubMed ID: 22589245
[TBL] [Abstract][Full Text] [Related]
15. PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.
Nelson MD; Rader F; Tang X; Tavyev J; Nelson SF; Miceli MC; Elashoff RM; Sweeney HL; Victor RG
Neurology; 2014 Jun; 82(23):2085-91. PubMed ID: 24808022
[TBL] [Abstract][Full Text] [Related]
16. Effect of sildenafil on skeletal and cardiac muscle in Becker muscular dystrophy.
Witting N; Kruuse C; Nyhuus B; Prahm KP; Citirak G; Lundgaard SJ; von Huth S; Vejlstrup N; Lindberg U; Krag TO; Vissing J
Ann Neurol; 2014 Oct; 76(4):550-7. PubMed ID: 25042931
[TBL] [Abstract][Full Text] [Related]
17. Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.
Thomas GD; Ye J; De Nardi C; Monopoli A; Ongini E; Victor RG
PLoS One; 2012; 7(11):e49350. PubMed ID: 23139842
[TBL] [Abstract][Full Text] [Related]
18. Neuronal nitric oxide synthase (nNOS) splice variant function: Insights into nitric oxide signaling from skeletal muscle.
Balke JE; Zhang L; Percival JM
Nitric Oxide; 2019 Jan; 82():35-47. PubMed ID: 30503614
[TBL] [Abstract][Full Text] [Related]
19. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
Wang S; Shen D
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
[TBL] [Abstract][Full Text] [Related]
20. miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context.
Guilbaud M; Gentil C; Peccate C; Gargaun E; Holtzmann I; Gruszczynski C; Falcone S; Mamchaoui K; Ben Yaou R; Leturcq F; Jeanson-Leh L; Piétri-Rouxel F
Skelet Muscle; 2018 Apr; 8(1):15. PubMed ID: 29703249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
